Glaxo: New product lines will reverse falling sales

Pharmaceutical giant GlaxoSmithKline has said it has a health portfolio of new products in the pipe-line that will reverse their falling sales.

Turnover fell by 2% in the three months to the end of 2011, leaving full-year sales down 3% at $43.5bn.